The Use of Protease Inhibitors in Pregnancy: Maternal and Fetal Considerations

Table 3

Selected pregnancy outcomes in HIV-infected women according to protease inhibitor use.

	ART with a protease inhibitor	ART without a protease inhibitor	No ART	value
Gestational age at delivery, weeks	38.0 ± 2.3	38.5 ± 2.2	37.8 ± 3.0		0.003
Preterm birth <37 weeks	82 (14)	31 (13)	37 (21)	0.049
Preterm birth <34 weeks	26 (4)	11 (5)	18 (10)	0.01
Birth weight, grams	3010 ± 607	3080 ± 657	2904 ± 686	0.02
SGA	116 (19)	54 (23)	39 (22)	0.4

Data reported as mean ± SD, median (quartiles), or (%) as appropriate.
SGA: small-for-gestational-age defined as less than 10th percentile for gestational age.
values demonstrate a significance between women who did not receive ART and the other two groups.